299 related articles for article (PubMed ID: 15351544)
21. Natural killer and lymphokine-activated killer activity in HLA-B8,DR3-positive subjects.
Caruso C; Candore G; Colucci AT; Cigna D; Modica MA; Tantillo G; Salerno A
Hum Immunol; 1993 Nov; 38(3):226-30. PubMed ID: 8106282
[TBL] [Abstract][Full Text] [Related]
22. Occupational Exposure to Chromium of Assembly Workers in Aviation Industries.
Genovese G; Castiglia L; Pieri M; Novi C; d'Angelo R; Sannolo N; Lamberti M; Miraglia N
J Occup Environ Hyg; 2015; 12(8):518-24. PubMed ID: 25793365
[TBL] [Abstract][Full Text] [Related]
23. Occupational exposure to hexavalent chromium. Final rule.
Occupational Safety and Health Administration (OSHA), Department of Labor
Fed Regist; 2006 Feb; 71(39):10099-385. PubMed ID: 16528853
[TBL] [Abstract][Full Text] [Related]
24. [T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].
Kuntz BM; Sobieraj B; Brüster HT
Beitr Infusionsther Transfusionsmed; 1994; 32():310-3. PubMed ID: 9480115
[TBL] [Abstract][Full Text] [Related]
25. Is hexavalent chromium carcinogenic via ingestion? A weight-of-evidence review.
Proctor DM; Otani JM; Finley BL; Paustenbach DJ; Bland JA; Speizer N; Sargent EV
J Toxicol Environ Health A; 2002 May; 65(10):701-46. PubMed ID: 12028825
[TBL] [Abstract][Full Text] [Related]
26. Resistance/susceptibility to Echinococcus multilocularis infection and cytokine profile in humans. II. Influence of the HLA B8, DR3, DQ2 haplotype.
Godot V; Harraga S; Beurton I; Tiberghien P; Sarciron E; Gottstein B; Vuitton DA
Clin Exp Immunol; 2000 Sep; 121(3):491-8. PubMed ID: 10971516
[TBL] [Abstract][Full Text] [Related]
27. Contribution of MHC class I chain-related A (MICA) gene polymorphism to genetic susceptibility for systemic lupus erythematosus.
Gambelunghe G; Gerli R; Bocci EB; Del Sindaco P; Ghaderi M; Sanjeevi CB; Bistoni O; Bini V; Falorni A
Rheumatology (Oxford); 2005 Mar; 44(3):287-92. PubMed ID: 15522921
[TBL] [Abstract][Full Text] [Related]
28. Field evaluation of a sampling and analytical method for environmental levels of airborne hexavalent chromium.
Sheehan P; Ricks R; Ripple S; Paustenbach D
Am Ind Hyg Assoc J; 1992 Jan; 53(1):57-68. PubMed ID: 1590220
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
30. Systemic uptake of chromium in human volunteers following dermal contact with hexavalent chromium (22 mg/L).
Corbett GE; Finley BL; Paustenbach DJ; Kerger BD
J Expo Anal Environ Epidemiol; 1997; 7(2):179-89. PubMed ID: 9185011
[TBL] [Abstract][Full Text] [Related]
31. HLA in Egyptian children with biliary atresia.
A-Kader HH; El-Ayyouti M; Hawas S; Abdalla A; Al-Tonbary Y; Bassiouny M; Boneberg A; El-Sallab S
J Pediatr; 2002 Sep; 141(3):432-3. PubMed ID: 12219069
[TBL] [Abstract][Full Text] [Related]
32. [Chromium content in erythrocytes serving as the exposure biomarker for workers exposed to soluble chromate].
Zhang J; Li GR; Liu LZ; Zhang N; Wang TC; Yan L; Jia G; Wang X
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Nov; 40(6):390-4. PubMed ID: 17313737
[TBL] [Abstract][Full Text] [Related]
33. Markers of T lymphocyte activation in HLA-B8, DR3 positive individuals.
Modica MA; Zambito AM; Candore G; Caruso C
Immunobiology; 1990 Nov; 181(4-5):257-66. PubMed ID: 2129202
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1.
Hashimoto S; Michalski JP; Berman MA; McCombs C
Clin Exp Immunol; 1990 Feb; 79(2):227-32. PubMed ID: 2311300
[TBL] [Abstract][Full Text] [Related]
35. HLA-B8,DR3 phenotype and lymphocyte responses to phytohaemagglutinin.
Modica MA; Cammarata G; Caruso C
J Immunogenet; 1990; 17(1-2):101-7. PubMed ID: 2212697
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune-associated HLA-B8-DR3 haplotypes in Asian Indians are unique in C4 complement gene copy numbers and HSP-2 1267A/G.
Kaur G; Kumar N; Szilagyi A; Blasko B; Fust G; Rajczy K; Pozsonyi E; Hosso A; Petranyi G; Tandon N; Mehra N
Hum Immunol; 2008 Sep; 69(9):580-7. PubMed ID: 18657583
[TBL] [Abstract][Full Text] [Related]
37. Hypothesis: interleukin-5 production impairment can be a key point in the pathogenesis of the MHC-linked selective IgA deficiency.
Lio D; D'Anna C; Leone F; Currò MF; Candore G; Caruso C
Autoimmunity; 1998; 27(3):185-8. PubMed ID: 9609136
[TBL] [Abstract][Full Text] [Related]
38. In vitro impairment of interleukin-5 production in HLA-B8, DR3-positive individuals implications for immunoglobulin A synthesis dysfunction.
Lio D; D'Anna C; Gervasi F; Cigna D; Modica MA; Candore G; Caruso C
Hum Immunol; 1995 Nov; 44(3):170-4. PubMed ID: 8666553
[TBL] [Abstract][Full Text] [Related]
39. The simultaneous detection of trivalent & hexavalent chromium in exhaled breath condensate: A feasibility study comparing workers and controls.
Leese E; Morton J; Gardiner PHE; Carolan VA
Int J Hyg Environ Health; 2017 Apr; 220(2 Pt B):415-423. PubMed ID: 27956251
[TBL] [Abstract][Full Text] [Related]
40. Effect of chromium on the level of IL-12 and IFN-gamma in occupationally exposed workers.
Katiyar S; Awasthi SK; Srivastava JK
Sci Total Environ; 2009 Mar; 407(6):1868-74. PubMed ID: 19144391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
